Related Experiment Video
Updated: Jun 7, 2025
Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
Published on: June 20, 2018
Endoscopic Submucosal Resection Turbinoplasty and Partial Inferior Turbinectomy for Management of Inferior Turbinate
Sabry Habshey Easa1, Talaat Mahrous Farghaly2, El Sayed Said Elswaby3
1Lecturer of Otorhinolaryngology, Faculty of Medicine, Al-Azhar University, Assiut, MD Egypt.
Objectives:
This study aims to compare outcomes of endoscopic submucosal resection Turbinoplasty and partial inferior turbinectomy in the treatment of Chronic inferior turbinate hypertrophy.
Methods:
A randomized prospective comparative study was conducted on 40 patients who complained of a minimum 3-month duration of nasal obstruction combined with clinical findings of moderate to severe inferior turbinate hypertrophy. Patients were divided into two groups: Group A (Endoscopic submucosal resection Turbinoplasty), and Group B (partial inferior turbinectomy) Which included 20 patients in each group. The outcomes of both techniques were analyzed and compared.
Results:
A total of 40 patients were randomized with 20 patients assigned to each group. Within each group, there were 12 (60%) females and 8 (40%) males. The median age in Group A was 22.7 (IQR, 7.50), and 26.5 (IQR, 15.5) in Group B. There were statistically significant differences between the two groups regarding nasal obstruction, nasal discharge, and crustations favoring Group A (p < 0.001, 0.003, 0.013 respectively). Additionally, there was a statistically significant increase in anterior nasal space postoperatively in Group A over Group B (p < 0.001) while a statistically significant increase in posterior nasal space was detected in Group B over Group A (p < 0.001). Also, there was a statistically significant reduction in turbinate size anteriorly and posteriorly in Group B over Group A (p < 0.001).
Conclusion:
submucosal resection Turbinoplasty is a safe and reliable technique of high efficacy and minimal complications that allows precise excision of hypertrophied stromal tissue in a submucosal plane which protects the physiological function of overlying respiratory precious mucosa and has minimal complications.
Trial Registration:
the trial was retrospectively registered at Clinical Trail.Gov identifier: NCT06310083.
